MSPR vs CLCO vs RPAY vs HIMS vs ATAI

For growth investors, MSP Recovery, Inc.

(MSPR) is the stronger pick with 136. 8% revenue growth year-over-year, versus -10. 8% for Cool Company Ltd. (CLCO). Cool Company Ltd. (CLCO) offers the better valuation at 5. 3x trailing P/E (12. 1x forward), making it the more compelling value choice. Analysts rate Repay Holdings Corporation (RPAY) a "Buy" — based on 17 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Cool Company Ltd.

(CLCO) is the cheapest at 5. 3x versus Hims & Hers Health, Inc. at 50. 3x. On forward P/E, Repay Holdings Corporation is actually cheaper at 3. 9x — notably different from the trailing picture, reflecting expected earnings growth.

Over the past 5 years, Hims & Hers Health, Inc.

(HIMS) delivered a total return of +137. 6%, compared to -99. 8% for MSP Recovery, Inc. (MSPR). Over 10 years, the gap is even starker: HIMS returned +161. 9% versus MSPR's -99. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Cool Company Ltd.

(CLCO) is the lower-risk stock at 0. 16β versus Hims & Hers Health, Inc. 's 2. 40β — meaning HIMS is approximately 1394% more volatile than CLCO relative to the S&P 500. On balance sheet safety, Atai Beckley N. V (ATAI) carries a lower debt/equity ratio of 21% versus 2% for Hims & Hers Health, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), MSP Recovery, Inc.

(MSPR) is pulling ahead at 136. 8% versus -10. 8% for Cool Company Ltd. (CLCO). On earnings-per-share growth, the picture is similar: Hims & Hers Health, Inc. grew EPS -3. 8% year-over-year, compared to -26. 3% for Repay Holdings Corporation. Over a 3-year CAGR, HIMS leads at 64. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Cool Company Ltd.

(CLCO) is the more profitable company, earning 30. 4% net margin versus -484. 6% for Atai Beckley N. V — meaning it keeps 30. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CLCO leads at 50. 5% versus -333. 4% for ATAI. At the gross margin level — before operating expenses — ATAI leads at 100. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Repay Holdings Corporation (RPAY) trades at 3.

9x forward P/E versus 51. 5x for Hims & Hers Health, Inc. — 47. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ATAI: 199. 3% to $12. 00.

In this comparison, CLCO (14.

2% yield) pays a dividend. MSPR, RPAY, HIMS, ATAI do not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Cool Company Ltd.

(CLCO) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 16), 14. 2% yield). Hims & Hers Health, Inc. (HIMS) carries a higher beta of 2. 40 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (CLCO: +1. 9%, HIMS: +161. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (MSPR (Healthcare) and CLCO (Industrials) and RPAY (Technology) and HIMS (Healthcare) and ATAI (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: MSPR is a small-cap high-growth stock; CLCO is a small-cap deep-value stock; RPAY is a small-cap quality compounder stock; HIMS is a small-cap high-growth stock; ATAI is a small-cap quality compounder stock. CLCO pays a dividend while MSPR, RPAY, HIMS, ATAI do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.